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Abstract 
HIV infection of CD4+ peripheral blood lymphocytes leads to a loss of MHC dass I 
molecules on the surface of the infected cells as detectable by monodonal antibody staining 
and flow cytometry. Incubation of the infected cells at 26 oe or treatment at 37 oe with 
peptides leads to upregulation of MHC dass I to levels equal to those found on uninfected cells 
cultured und er the same conditions. The data suggest that, after HIV infection, the mechan-
isms responsible for peptide generation, peptide transport and thus stable association between 
peptides and MHC dass I molecules are severely affected. 
Introduction 
Following virus infection a variety of host defense mechanisms are being 
mobilized by the organism, induding the activation of CD8+ cytolytic T 
lymphocytes which eventually help to eliminate virus infected cells. These 
CD8+ T cells recognize antigenic fragments in the context of major 
histocompatibility dass I (MHC dass I) molecules which bind and trans-
port peptides derived from intracellularly degraded proteins to the ceU 
surface, where the dass I1peptide complexes are recognized by the T ceUs 
(1-6). A failure to express such complexes on the surface of infected ceUs 
would thus be expected to severely compromise the host and favor virus 
spread. To escape the hosts' defensive mechanisms, several viruses have 
developed strategies that lead to downregulation of MHC dass I expression 
on the surface of the ceUs in which they replicate (reviewed in 7). Thus, 
adenovirus 12 inhibits dass I production at the transcriptionallevel, while 
other virus es either bind ß2 microglobulin or the heavy chain of dass land 
thus prevent their export, together with viral peptides, to the cell surface. 
We and others (8, 9) have previously shown that HIV infection of 
peripheral blood lymphocytes or susceptible ceU lines also leads to a 
reduction of dass I expression on the surface of those ceUs heavily infected. 
Since we found that the amounts of dass I specific mRNA were similar in 
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infected and uninfected cells, it seemed likely that dass I downregulation 
was due to posttranscriptional or posttranslational mechanisms. The pres-
ent study was undertaken to more dosely analyze the basis for the escape 
mechanism from the immune system operative in HIV infection. 
Material and Methods 
Cell culture and HIV inEection 
From buffy coat cells of HIV negative donors CD8+ cells were removed by a magnet after 
complexing them to Dynabeads (Dianova, Hamburg, Germany) coupled with a monoclonal 
antibody to human CD8. The resulting CD8- cells were cultured in RPMIII0 % FCS at a cell 
cOllcentration of 1 X 106/ml for 2 days with phytohemagglutinin (PHA-P; Difco, Detroit, MI, 
USA, 2 [lg/ml) in the presence of human rIL-2 (40 U/ml, a kind gift of PROF. SEBALD, 
Würzburg). Half of the cells were then infected with an MOl of 0.1 of HIV-l (HTL VIII B), 
the other half remained uninfected as a contro!. 
Upregulation oE MHC dass I at low temperature or by peptides 
Aliquots of the infected or uninfected cells were placed in a 26°C water bath for the last 6 h of a 
4 day culture period, after which time all cells were processed for surface fluorescence staining. 
Alternatively, 5 x lOs cell aliquots of the infected cultures were exposed for the last 5 h of a 
4 day culture period at 37"C to HIV gag peptide p 17-8 or p17-3 (Cambridge Research 
Biochemicals, England) at a concentration of 1 x 10--4 M in a total volume of 1.4 m!. 
Immunofluorescence staining and FACS analysis 
On day 4 after infection, aliquots from controls and infected cultures - cultured at 37°CI 
26°C or treated with peptides as described above - were incubated with the following 
antibodies for 30 min on ice: mAb W6/32 (Serotec, Indianapolis, IN, USA), antihuman ß2-
microglobulin polyclonal antibody (DAKO, Hamburg, Germany), anti HLA A2 mAb and 
anti HLA Bw6 mAb (Biotest, Dreieich, Germany). The cells were washed twice in PBS and 
then incubated with 0.1 ml fluorescein isothiocyanate (FITq-conjugated gdat anti-mouse 
immunoglobulin (Dianova, Hamburg) or FITC-conjugated swine anti-rabbit-immunoglobu-
!in (DAKOPATTS, Denmark) for 30 min on ice, washed twice in PBS, fixed in 3.5 % 
formaldehyde and analyzed on a FACScan (Becton Dickinson, Heidelberg, Germany). 
Results and Discussion 
During our investigations of the mechanisms responsible for the down-
regulation of MHC dass I molecules in HIV-1 infected CD4+T-cells, we 
were puzzled by the observation that the extent of downregulation varied 
between individual blood donors and, occasionally, was more pronounced 
for ß2 microglobulin than for the heavy chain of dass I (Fig. 1). In view of 
the comparable amounts of dass I heavy chain specific mRNA in infected 
and uninfected cells (8) and the recent finding that ß2-microglobulin loss 
from «empty» MHC dass I molecules may precede loss of total dass I 
complexes from the surface (10) we suspected that a posttranslational 
mechanism, possibly affecting the stability of dass I1ß2 complexes, was 
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operative. The phenomenon was thus reminiscent of the reduced MHC 
dass I expression recently described for the mutant mouse cellline RMA-S 
(11, 12) which appears to have a defect in the transport of peptide to the 
MHC dass I moleeules resulting in drastically reduced dass I surface 
expression. The empty dass I moleeules thus formed are unstable at 37 oe 
and those moleeules still exported to the surface rapidly lose ß2-micro-
globulin. At reduced temperature (26°C) the complexes can be stabilized. 
They can also be stabilized by peptides bin ding to the dass I moleeule in 
question, or by ß2 microglobulin at body temperature (5, 6, 10, 13-15). 
To see whether an instability of MHC dass I might also be responsible 
for the loss of surface MHC dass I in HIV-infected cells, we infected PBL's 
of an HIV negative donor with HIV in vitro. At day 4 after infection we 
observed in a proportion of cells previously shown to be those that are 
heavily infected (8), a downregulation on the cell surface of, in this case, 
beta 2 anti CI 1-heavy chain 
b 
11 l\ 
" 
11 
1 \ I. t I-
11 t I 
. I I 
:: \ l\ .. :.1 \ • ·1 
.-:. \: . ;. \ 
I' 
-.... "~ 
113 1 113 2 10"" Hl'" "al ,~2 1",:0: 
d 
Figure 1. Indirect immunofluorescence staining of uninfected (--) and HIV -infected (- ...... ) 
PBL's of two different blood donors with anti-human ß2-microglobulin (a+c) or with 
monoclonal antibody W6/32 directed against dass 1 heavy chain (b+d). 
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both the heavy and light chain of dass I (Fig. 2). When we cultured the 
infected cells at 26 oe for 6 hand subsequently measured the expression of 
dass I moleeules on the surface by fluorescence analysis we observed a 
marked increase of dass I moleeules to values equal to those found in 
uninfected cells also cultured at 26 oe. The surface fluorescence of both 
populations surpassed that observed in uninfected cells cultured at 3re 
(Fig. 2), in keeping with previous reports showing that some empty MHC 
dass I molecules are always present even in normal cells and can be 
stabilized at low temperatures (10). Since in spite of equal numbers of p24 
positive cells (data not shown) increased surface dass I on HIV infected 
cells could be due to inefficient virus replication at the reduced temperature, 
we attempted to upregulate surface MHC dass I expression by the addition 
ofpeptides at 37 oe. In this experiment PBL's were infected that derived 
from an A2 donor which also reacted with the broad specificity anti HLA-
B monodonal antibody Bw6. Figure 3 shows reduced staining with both 
HIV-infected 
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Figure 2. Expression of class I-heavy chain (a+b) and ß2-microglobulin (c+d) on uninfected 
and HIV-infected cells cultured at 3rc (--) or at 26°C ( ....... ) for the last 6h of a 4 day 
culture period. 
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Figure 3. Expression of HLA A2 (a-d) or HLA Bw6 (e-h) on HIV-infected PBL's after exposure to various peptides for the last 5h of a 4 day 
culture period. a+e, uninfected control culture; b+f, PBL's infected with HIV-l for 4 days; c+g, PBL's infected with HIV-l for 4 days and 
exposed to peptide p 17-8 for 5h; d+h, PBL's infected with HIV-l for 4 days and exposed to peptide p 17-3 for 5h. 
-'" o 
0' 
;l 
~ 
~ 
:>-
~ 
'" Cl
~ 
m 
.~ 
o 
~ 
m 
.~ 
., 
::> 
0-
?> 
(J) 
n 
:r: 
~ 
'" r 
MHC Class I Downregulation in HIV . 407 
anti-A2 and anti-Bw6 mAb in a proportion of cells. Exposure of the 
infected cells to exogenous A2 binding peptide p17-8 (16) for sh dearly 
increased the expression of HLA A2 (Fig. 3c) whereas the B8 binding 
peptide p17-3 (16) failed to do so (Fig. 3d). The peptide p 17-8 was also 
shown to upregulate dass I molecules reacting with the anti-Bw6 antibody 
(Fig. 3g) while p17-3 (Fig. 3h) did not. Unfortunately we do not have any 
information on the HLA-B binding properties of these two peptides. 
However, it has been shown that peptide binding may occasionally be 
promiscuous (16-18). 
Our data indicate that HIV -infected cells behave very similarly to RMA-
S cells with respect to reversion of dass I surface expression, suggesting a 
defect in peptide generation/transport or loading of dass I in the virus 
infected cells. Peptides derived from cytosolic proteins assemble with MHC 
dass I molecules in the endoplasmatic reticulum or pre Golgi compartment 
(5, 19). In the absence of recognizable N-terminal signal sequences, such 
cytosolic peptides must be translocated across the membranes of the 
endoplasmatic reticulum by a novel mechanism. Recently, several inves-
tigators described the doning-and-sequencing of «novel» genes encoded 
within the MHC which are candidates for peptide transporters (20-23) and 
may supply nascent dass I MHC molecules with peptides, thereby fuelling 
the endogenous pathway of antigen presentation. Since downregulation of 
MH C dass I molecules in HIV -1 infected cells can be overcome either by 
culture at reduced temperature or by the exposure to extracellular peptides 
we suggest the following hypothesis: In HIV -1 infected cells peptide 
generation and/or the peptide transporters may be «switched off» - possi-
bly by HIV-1 derived gene products. As a consequence of this, MHC dass 
I molecules would remain empty. Such empty dass I molecules would 
either not associate with ß2-microglobulin and not be transported further 
to the cell surface or, if so, be unstable at body temperature. Differences in 
the stabilities of different MHC Class I allelic products, as recently sug-
gested for B27 (24) might account for the variations in dass I downregula-
tion observed between different blood donors. Also, loss of ß2 has been 
shown to affect the conformation of the heavy chains still residing in the 
membrane (10). Conformational stability after ß2loss may vary from allele 
to allele and thus render detection by the monodonal antibody used more 
or less efficient. 
A number of observations previously reported for AIDS patients could 
be explained on the basis of our findings. Thus, the increase in circulating 
ß2-microglobulin in sera of patients infected with HIV (25) might may be 
due to ß2-microglobulin chains having dissociated from peptide-less, un-
stable MHC complexes. This would eventually lead to the progressive 
decrease of MHC dass I-positive lymphocytes and a defective expression of 
dass I molecules recently reported for AIDS patients (26). Since peptide 
loading would not be possible in infected cells, the data could also explain 
why the CD8+ cytotoxic T cells detectable in vitra on target cells either 
incubated with peptides or infected with recombinant vaccinia virus 
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expressing individual HIV proteins (27-30) do not seem to be very effieient 
in eontaining or terminating the disease in vivo. The unusally high fre-
queney of CD4+, Class II restrieted eytolytie T eells observed in HIV 
positive donors might refleet an attempt of the host to eompensate for the 
loss of an effieient dass I restrieted eytolytie response. 
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